Login / Signup

Preclinical Common Data Elements for General Pharmacological Studies (Pharmacokinetic Sample Collection, Tolerability, and Drug Administration). A Report of the TASK3-WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force.

Lisa ColesPatrick A ForcelliKarine LeclercqAnna-Maria KatsarouBrian D KleinHeidrun PotschkaRüdiger KöhlingLauren Harte-HargroveAristea S GalanopoulouCameron S Metcalf
Published in: Epilepsia open (2023)
Growing concerns over rigor and reproducibility of preclinical studies, including consistency across laboratories and translation to clinical populations, have triggered efforts to harmonize methodologies. This includes the first set of preclinical common data elements (CDEs) for epilepsy research studies, as well as Case Report Forms (CRFs) for widespread use in epilepsy research. The General Pharmacology Working Group of the ILAE/AES Task Force (TASK3-WG1A) has continued in this effort by adapting and refining CDEs/CRFs to address specific study design areas as they relate to preclinical drug screening: general pharmacology, pharmacokinetics (PK) and pharmacodynamics (PD), and tolerability. This work has expanded general pharmacology studies to include dose records, PK/PD, tolerability, and elements of rigor and reproducibility. Tolerability testing CRFs included rotarod and Irwin/Functional Observation Battery assays. The material provided in the form of CRFs can be delivered for widespread use within the epilepsy research community.
Keyphrases